Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 6.63% |
| RADIANT LOGI | RLGT | 6.38% |
| FEDERAL MOGU | FDML | 5.80% |
| NATUS MEDICA | BABY | 5.34% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Mining giant, Vale S.A. ( VALE - Analyst Report ) recently released its financial results for the fourth quarter and full-year 2012. Underlying earnings per ADR declined 57.8% year over year and 83.0% sequentially to 38 cents per share (on a fully diluted basis) in the quarter.
Results also failed to meet the Zacks Consensus Estimate of 50 cents per ADR. Weak global economy as well as low prices for most of its products severely impacted revenue.
For 2012, Vale reported earnings per ADR of $2.20, declining almost 50.3% compared with the year-ago earnings of $4.43. However, earnings beat the Zacks Consensus Estimate of $2.07 per ADR.
Revenue: Operating revenue plunged 18.7% year over year to $12.0 billion. However, it increased by 9.5% sequentially and also beat the Zacks Revenue Estimate of $11.4 billion by 5.1%. The year-over-year decrease in revenue was a result of lower prices for its products other than gold. However, the prices were slightly better sequentially. Also, an increase in volume of production, especially iron ore, helped the sequential increase.
Of the total revenue, sales of ferrous minerals accounted for 70.2%; coal sales 1.7%; base metals sales 15.1%; fertilizer nutrients sales 7.7%; logistics services sales 3.2%; and the remaining 2.1% came from sales of miscellaneous sources.
Geographically, 18.3% of revenue was generated from South America, 56.8% from Asia, 4.6% from North America, 16.3% from Europe, 2.8% from the Middle East and 1.2% from Rest of the World.
Revenue dropped 23.1% year over year in 2012 to $46.5 billion, resulting from a decline in the prices of metals and minerals across the year. However, revenues slightly beat the Zacks Consensus Estimate of $45.0 billion.
Margins: In the fourth quarter, cost of goods sold totaled $6.5 billion, increasing 720 basis points year over year, due to an increase in the freight costs. SG&A and R&D expenses were $577.0 million and $460.0 million declining 30.2% and 13.0% year over year, respectively. This resulted from Vale’s initiatives to curb costs.
Lower prices of the products pulled down the adjusted operating income by 51.2% year over year to $2.9 billion in the quarter.
Balance Sheet/Cash Flow: Exiting the fourth quarter of 2012, Vale’s cash and cash equivalents were recorded at $5.8 billion versus $8.0 billion in the previous quarter. Long-term debt increased to $43.0 billion compared with $42.4 billion in the previous quarter.
Net cash generated from operating activities was $3.4 billion versus $7.5 billion in the year-ago quarter while capital spending came in at $4.8 billion versus $6.1 billion in the fourth quarter of 2011.
Outlook: In the coming quarters, management expects its cost saving strategies to pay-off, which in turn will increase the earnings of the company.
The stock currently bears a Zacks Rank #3 (Hold). Other stocks in the minerals industry worth a look are Kumba Iron Ore Ltd. ( KIROY ) ; holding a Zacks Rank #1 (Strong Buy), and Commercial Metals Company ( CMC - Snapshot Report ) and Gibraltar Industries Inc. ( ROCK - Analyst Report ) both of which hold a Zacks Rank #2 (Buy).
Read the full Analyst Report on VALE
Read the full Analyst Report on ROCK
Read the full on KIROY
Read the full Snapshot Report on CMC